← Leaderboards
Prescott G Woodruff
University Of California San Francisco
$62,639,366
Attributed
$85,197,056
Total exposure
21
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$85,197,056 · 21
By mechanism
U01$50,231,179 · 4
N01$11,512,211 · 2
U19$7,179,048 · 6
R01$6,666,620 · 3
T32$3,901,542 · 1
P01$3,876,858 · 3
Top collaborators
- David J Erle10 shared
- Mario Castro8 shared
- Suzy Comhair8 shared
- Loren C Denlinger8 shared
- Eric A Hoffman8 shared
- Elliot Israel8 shared
- Purveshkumar Khatri8 shared
- Bruce D Levy8 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Esteban Gonzalez Burchard$36,575,876
- John V Fahy$35,378,030
- David J Erle$39,345,888
- Homer A Boushey$9,020,633
- Laurence Huang$20,236,114
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationSamplingAsthmaBaseGenomicsPhenotypeEnrollmentClinical ResearchMolecularBiologicalPathway InteractionsLungLung DiseasesInflammatoryGrantBioinformaticsCellsSeveritiesCharacteristicsResourcesResponseTargeted TreatmentAirway InflammationSubgroup
Grant awards (91)
SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III$7,037,497
N01 · FY2025 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,316,196
T32 · FY2025 · HL · contact PI
Project 2: Micro-RNA and ER stress regulation of pathological mucus in type 2-high asthma$350,269
U19 · FY2025 · AI · contact PI
SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - SPIROMICS - TASK AREA B$197,163
N01 · FY2025 · HL · contact PI
Mentoring Research in Precision Medicine for Lung Disease$121,148
K24 · FY2025 · HL · contact PI
Multidisciplinary Training Program in Lung Disease$1,331,043
T32 · FY2024 · HL · contact PI
Project 2: Micro-RNA and ER stress regulation of pathological mucus in type 2-high asthma$484,500
U19 · FY2024 · AI · contact PI
Mentoring Research in Precision Medicine for Lung Disease$121,148
K24 · FY2024 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,233,979
U01 · FY2023 · HL
Multidisciplinary Training Program in Lung Disease$1,254,303
T32 · FY2023 · HL · contact PI
Project 2: Micro-RNA and ER stress regulation of pathological mucus in type 2-high asthma$484,500
U19 · FY2023 · AI · contact PI
Core C - Biospecimans and Bioinformatics Core$370,042
P01 · FY2023 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$216,239
U01 · FY2023 · HL
Mentoring Research in Precision Medicine for Lung Disease$121,148
K24 · FY2023 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,322,614
U01 · FY2022 · HL
Beyond the Type-2 High Endotype: Interferons and Epithelial ER Stress in Asthma$522,202
U19 · FY2022 · AI · contact PI
Rapid saliva antigen test for SARS-CoV-2 detection$434,002
U01 · FY2022 · HL
Core C - Biospecimans and Bioinformatics Core$370,042
P01 · FY2022 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$235,989
U01 · FY2022 · HL
Mentoring Research in Precision Medicine for Lung Disease$121,148
K24 · FY2022 · HL · contact PI
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression$3,589,191
U01 · FY2021 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,058,207
U01 · FY2021 · HL
Beyond the Type-2 High Endotype$551,676
U19 · FY2021 · AI · contact PI
Beyond the Type-2 High Endotype: Interferons and Epithelial ER Stress in Asthma$471,839
U19 · FY2021 · AI · contact PI
Core C - Biospecimans and Bioinformatics Core$370,042
P01 · FY2021 · HL · contact PI
Mentoring research in precision medicine for lung disease$120,373
K24 · FY2021 · HL · contact PI
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$89,962
R01 · FY2021 · HL
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression$3,976,480
U01 · FY2020 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,355,708
U01 · FY2020 · HL
Beyond the Type-2 High Endotype$1,117,573
U19 · FY2020 · AI · contact PI
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$752,810
R01 · FY2020 · HL
Beyond the Type-2 High Endotype: Interferons and Epithelial ER Stress in Asthma$467,892
U19 · FY2020 · AI · contact PI
Core C - Biospecimans and Bioinformatics Core$370,042
P01 · FY2020 · HL · contact PI
Redefining Therapy In Early COPD: RETHINC$200,000
U01 · FY2020 · HL
Mentoring research in precision medicine for lung disease$120,373
K24 · FY2020 · HL · contact PI
Enhancing the I AM GOLD study with single-cell deep phenotyping and machine learning meta-analysis$89,962
R01 · FY2020 · HL
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression$6,528,627
U01 · FY2019 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,419,613
U01 · FY2019 · HL
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$774,747
R01 · FY2019 · HL
Beyond the Type-2 High Endotype: Interferons and Epithelial ER Stress in Asthma$432,338
U19 · FY2019 · AI · contact PI
Core C - Biospecimans and Bioinformatics Core$383,437
P01 · FY2019 · HL · contact PI
Mentoring research in precision medicine for lung disease$120,373
K24 · FY2019 · HL · contact PI
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression$7,089,002
U01 · FY2018 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$677,024
U01 · FY2018 · HL · contact PI
Beyond the Type-2 High Endotype: Interferons and Epithelial ER Stress in Asthma$481,794
U19 · FY2018 · AI · contact PI
Redefining Therapy In Early COPD: RETHINC$324,359
U01 · FY2018 · HL
Mentoring research in precision medicine for lung disease$120,584
K24 · FY2018 · HL · contact PI
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression$83,640
U01 · FY2018 · HL · contact PI
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression$6,596,265
U01 · FY2017 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$677,024
U01 · FY2017 · HL · contact PI
Redefining Therapy In Early COPD: RETHINC$333,077
U01 · FY2017 · HL
Clinical Subject and Biospecimen Core$264,722
U19 · FY2017 · AI · contact PI
Mentoring research in precision medicine for lung disease$119,453
K24 · FY2017 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$42,117
U01 · FY2017 · HL · contact PI
Biospecimen and Bioinformatics Core$853,442
P01 · FY2016 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$677,023
U01 · FY2016 · HL · contact PI
Clinical Subject and Biospecimen Core$402,786
U19 · FY2016 · AI · contact PI
Redefining Therapy In Early COPD: RETHINC$341,229
U01 · FY2016 · HL
SPIROMICS$146,250
N01 · FY2016 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$677,025
U01 · FY2015 · HL · contact PI
Biospecimen and Bioinformatics Core$443,886
P01 · FY2015 · HL · contact PI
Clinical Subject and Biospecimen Core$402,786
U19 · FY2015 · AI · contact PI
Redefining Therapy In Early COPD: RETHINC$363,496
U01 · FY2015 · HL
SPIROMICS Clinical Center$269,587
N01 · FY2015 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$79,250
U01 · FY2015 · HL · contact PI
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA$699,999
U01 · FY2014 · HL · contact PI
Clinical Subject and Biospecimen Core$369,533
U19 · FY2014 · AI · contact PI
Biospecimen and Bioinformatics Core$240,565
P01 · FY2014 · HL · contact PI
Clinical Subject and Biospecimen Core$374,638
U19 · FY2013 · AI · contact PI
Biospecimen and Bioinformatics Core$232,214
P01 · FY2013 · HL · contact PI
SPIROMICS$167,688
N01 · FY2013 · HL · contact PI
Role of Th2 and non-Th2 Inflammation in Airway Smooth Muscle Remodeling in Asthma$427,315
R01 · FY2012 · HL · contact PI
Biospecimen and Bioinformatics Core$243,146
P01 · FY2012 · HL · contact PI
SPIROMICS Clincial Center$28,492
N01 · FY2012 · HL · contact PI
Molecular Phenotyping of Asthma$748,204
R01 · FY2011 · HL · contact PI
Role of Th2 and non-Th2 Inflammation in Airway Smooth Muscle Remodeling in Asthma$437,294
R01 · FY2011 · HL · contact PI
SPIRIOMICS Clinical Center$226,469
N01 · FY2011 · HL · contact PI
SPIROMICS Clinical Center$2,123,897
N01 · FY2010 · HL · contact PI
SPIRIOMICS Clinical Center$1,210,341
N01 · FY2010 · HL · contact PI
Molecular Phenotyping of Asthma$755,813
R01 · FY2010 · HL · contact PI
Role of Th2 and non-Th2 Inflammation in Airway Smooth Muscle Remodeling in Asthma$445,403
R01 · FY2010 · HL · contact PI
Molecular Phenotyping of Asthma$748,530
R01 · FY2009 · HL · contact PI
Role of Th2 and non-Th2 Inflammation in Airway Smooth Muscle Remodeling in Asthma$509,511
R01 · FY2009 · HL · contact PI
Molecular Phenotyping of Asthma$147,546
R01 · FY2009 · HL · contact PI
SPIROMICS Clinical Center$104,827
N01 · FY2009 · HL · contact PI
Molecular Phenotyping of Asthma$739,523
R01 · FY2008 · HL · contact PI
MECHANISMS OF SMOOTH MUSCLE HYPERREACTIVITY ON ASTHMA$148,770
K23 · FY2006 · RR · contact PI
MECHANISMS OF SMOOTH MUSCLE HYPERREACTIVITY ON ASTHMA$148,770
K23 · FY2005 · RR
MECHANISMS OF SMOOTH MUSCLE HYPERREACTIVITY ON ASTHMA$148,770
K23 · FY2004 · RR
MECHANISMS OF SMOOTH MUSCLE HYPERREACTIVITY ON ASTHMA$148,770
K23 · FY2003 · RR
MECHANISMS OF SMOOTH MUSCLE HYPERREACTIVITY ON ASTHMA$148,770
K23 · FY2002 · RR